Last reviewed · How we verify

NCT04737395

Intensive Upper Extremity Training Program During the Early Subacute Phase After Stroke: A Feasibility Study

Status unknown NA Last updated 3 February 2021
What this trial tests

NA trial testing upper extremity training program ("Meditouch","MSQUARE") in Stroke in 20 participants. Status unknown.

Timeline
22 November 2020
Primary endpoint
22 November 2022
22 November 2022

Quick facts

Lead sponsorSheba Medical Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date22 November 2020
Primary completion22 November 2022
Estimated completion22 November 2022
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Sheba Medical Center

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study assesses the feasibility of a 4-week upper extremity training program emphasizing quality of movement practiced at high intensity and dosage applied during the early subacute phase after stroke.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Neurotechnology-Based, Intensive, Supplementary Upper-Extremity Training for Inpatients With Subacute Stroke: Feasibility Study.
    Binyamin-Netser R, Handelzalts S, Goldhamer N, Avni I, et al · · 2025 · cited 4× · PMID 39946405 · DOI 10.2196/56397

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Sheba Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04737395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing